Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
- Author
- STADTMAUER, E. A1 ; O'NEILL, A2 ; SICKLES, C1 ; GLICK, J. H1 ; GOLDSTEIN, L. J3 ; CRILLEY, P. A4 ; MANGAN, K. F5 ; INGLE, J. N6 ; BRODSKY, I4 ; MARTINO, S7 ; LAZARUS, H. M8 ; ERBAN, J. K9
[1] University of Pennsylvania Cancer Center, Philadelphia, United States
[2] Dana-Farber Cancer Institute, Boston, United States
[3] Fox Chase Cancer Center, Philadelphia, United States
[4] Hahnemann University, Philadelphia, United States
[5] Temple University, Philadelphia, United States
[6] Mayo Clinic, Rochester, Minn., United States
[7] John Wayne Cancer Institute, Santa Monica, Calif., United States
[8] University Hospitals of Cleveland, Cleveland, United States
[9] Tufts-New England Medical Center, Boston, United States
Philadelphia Bone Marrow Transplant Group, United States - Source
The New England journal of medicine. 2000, Vol 342, Num 15, pp 1069-1076 ; ref : 19 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Boston, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Autogreffe Cellule hématopoïétique Cellule souche Chimiothérapie Dose forte Femelle Glande mammaire Homme Métastase Pronostic Survie Traitement associé Tumeur maligne Glande mammaire pathologie Greffe
- Keyword (en)
- Antineoplastic agent Autograft Hematopoietic cell Stem cell Chemotherapy High dose Female Mammary gland Human Metastasis Prognosis Survival Combined treatment Malignant tumor Mammary gland diseases Graft
- Keyword (es)
- Anticanceroso Autoinjerto Célula hematopoyética Célula primitiva Quimioterapia Dosis fuerte Hembra Glándula mamaria Hombre Metástasis Pronóstico Sobrevivencia Tratamiento asociado Tumor maligno Glándula mamaria patología Injerto
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1330865
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJM200004133421501 
https://dx.doi.org/10.1056/NEJM200004133421501
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"342\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1069\";s:8:\"\u0000*\u0000epage\";s:4:\"1076\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"STADTMAUER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"O'NEILL, A\";i:1;s:10:\"SICKLES, C\";i:2;s:11:\"GLICK, J. H\";i:3;s:15:\"GOLDSTEIN, L. J\";i:4;s:13:\"CRILLEY, P. A\";i:5;s:12:\"MANGAN, K. F\";i:6;s:11:\"INGLE, J. N\";i:7;s:10:\"BRODSKY, I\";i:8;s:10:\"MARTINO, S\";i:9;s:13:\"LAZARUS, H. M\";i:10;s:11:\"ERBAN, J. K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"342\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1069\";s:8:\"\u0000*\u0000epage\";s:4:\"1076\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"STADTMAUER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"O'NEILL, A\";i:1;s:10:\"SICKLES, C\";i:2;s:11:\"GLICK, J. H\";i:3;s:15:\"GOLDSTEIN, L. J\";i:4;s:13:\"CRILLEY, P. A\";i:5;s:12:\"MANGAN, K. F\";i:6;s:11:\"INGLE, J. N\";i:7;s:10:\"BRODSKY, I\";i:8;s:10:\"MARTINO, S\";i:9;s:13:\"LAZARUS, H. M\";i:10;s:11:\"ERBAN, J. K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"342\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1069\";s:8:\"\u0000*\u0000epage\";s:4:\"1076\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"STADTMAUER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"O'NEILL, A\";i:1;s:10:\"SICKLES, C\";i:2;s:11:\"GLICK, J. H\";i:3;s:15:\"GOLDSTEIN, L. J\";i:4;s:13:\"CRILLEY, P. A\";i:5;s:12:\"MANGAN, K. F\";i:6;s:11:\"INGLE, J. N\";i:7;s:10:\"BRODSKY, I\";i:8;s:10:\"MARTINO, S\";i:9;s:13:\"LAZARUS, H. M\";i:10;s:11:\"ERBAN, J. K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"342\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1069\";s:8:\"\u0000*\u0000epage\";s:4:\"1076\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"STADTMAUER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"O'NEILL, A\";i:1;s:10:\"SICKLES, C\";i:2;s:11:\"GLICK, J. H\";i:3;s:15:\"GOLDSTEIN, L. J\";i:4;s:13:\"CRILLEY, P. A\";i:5;s:12:\"MANGAN, K. F\";i:6;s:11:\"INGLE, J. N\";i:7;s:10:\"BRODSKY, I\";i:8;s:10:\"MARTINO, S\";i:9;s:13:\"LAZARUS, H. M\";i:10;s:11:\"ERBAN, J. K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1056\/NEJM200004133421501\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"342\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1069\";s:8:\"\u0000*\u0000epage\";s:4:\"1076\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"STADTMAUER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"O'NEILL, A\";i:1;s:10:\"SICKLES, C\";i:2;s:11:\"GLICK, J. H\";i:3;s:15:\"GOLDSTEIN, L. J\";i:4;s:13:\"CRILLEY, P. A\";i:5;s:12:\"MANGAN, K. F\";i:6;s:11:\"INGLE, J. N\";i:7;s:10:\"BRODSKY, I\";i:8;s:10:\"MARTINO, S\";i:9;s:13:\"LAZARUS, H. M\";i:10;s:11:\"ERBAN, J. K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
